Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for The Beauty Health Company (SKIN:NASDAQ), powered by AI.
The Beauty Health Company is currently trading at $0.58. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for The Beauty Health Company on Alpha Lenz.
The Beauty Health Company's P/E ratio is -7.7.
“The Beauty Health Company trades at a P/E of -7.7 (undervalued) with modest ROE of -16.9%.”
Ask for details →The Beauty Health Company is a prominent player in the beauty and wellness industry, primarily engaging in the development and distribution of aesthetic technologies aimed at enhancing skin health. The company's flagship product is the HydraFacial, an innovative, non-invasive skincare treatment that combines cleansing, exfoliation, extraction, hydration, and antioxidant protection for rejuvenated skin. This technology is widely employed by medical spas, dermatologists, and aesthetic professionals, underscoring The Beauty Health Company's impact across both consumer and industrial applications. The Beauty Health Company thrives at the intersection of beauty and health, targeting a growing market of end-users seeking advanced skincare solutions. It is a significant contributor to the health and personal care sectors, with its robust portfolio of products and services designed to support skincare programs. Positioned as a leader in aesthetic technology, The Beauty Health Company continues to influence trends within the beauty industry, emphasizing the importance of combining technological innovation with consumer demand for effective skincare solutions. This dynamic role ensures that it stays at the forefront of developments in beauty technology and wellness.
“The Beauty Health Company trades at a P/E of -7.7 (undervalued) with modest ROE of -16.9%.”
Ask for details →The Beauty Health Company (ticker: SKIN) is a company listed on NASDAQ in the Consumer Defensive sector (Household & Personal Products). It has approximately 769 employees. Market cap is $73M.
The current price is $0.58 with a P/E ratio of -7.7x and P/B of 1.2x.
ROE is -16.87% and operating margin is -6.92%. Annual revenue is $301M.